BioMimetic Therapeutics (BMTI) Posts Q1 Loss of 22c
Tweet
Share
E-mailGet Alerts BMTI Hot Sheet
Price: $9.49 --0%
Financial Fact:
Research and development: 1.93M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 1.93M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) reported Q1 EPS of ($0.22), versus ($0.28) reported last year. Revenue for the quarter came in at $466.38 million, versus $398.7 million reported last year.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Optimum Communications gets NYSE non-compliance notice over stock price
- Diana Shipping drops bid for Genco after price demands spike to $36.91
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
